A CMC Reviewer s Perspective on the Quality Overall Summary. Arthur B. Shaw, Ph.D. FDA/CDER/ONDQA FDA DMF Expert June 15, 2010.
|
|
- Marilyn Logan
- 5 years ago
- Views:
Transcription
1 A CMC Reviewer s Perspective on the Quality Overall Summary and Module 3 Arthur B. Shaw, Ph.D. FDA/CDER/ONDQA FDA DMF Expert June 15, 2010 Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. ( DIA ) DIA), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated. For work prepared by US government employees representing their agencies, there is no copyright and these work products can be reproduced freely. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners. 2 1
2 Module 1 Admin ESub overview Module 2 Summary Includes Quality Overall Summary (QOS) Module 3 Quality Module 4 Safety Module 5 Efficacy Modules 1, 4 and 5 These modules contain important information related to CMC Module 1: Letters of Authorization to other applications, particularly Drug Master Files (DMFs) Modules 4 and 5: Information about batches used for safety studies and clinical trials. Important if there are issues regarding impurities and/or formulation changes during development. 2
3 Module Letter of Authorization (LOA) Submission by the owner of information, ato giving g authorization for the information to be used by another. Include in DMF Statement of Right of Reference Submission by recipient of a Letter of Authorization with a copy of the LOA and statement of right of reference. Include in NDA/IND. Do NOT place in S.2 or P [next slide] 1.14: Claim of categorical exclusion or environmental assessment Section 1.11 Information amendment: Information not covered under modules 2 to 5 From Guidance for Industry: Providing Regulatory Submissions in Electronic Format Human Pharmaceutical Product Applications and Related Submissions Using the ectd Specifications Page 11 You should include documents that are provided in information amendments in the appropriate module using the appropriate headings to describe the subject matter. In the unusual case when information amendments do not fit appropriately under any heading in the CTD, you should place the documents in module 1 under the heading information amendment: Information not covered under modules 2 to 5. 3
4 Scanned Images vs Text or OCR From the ECTD Guidance (Page 6) Scanned documents submitted electronically as images are not as useful for review as documents that are text based. Image-based documents are more difficult to read and cannot be electronically searched. It takes longer to print image-based documents, and they occupy more storage space than text-based t documents. For these reasons, we strongly urge that you provide text-based documents, rather than image files, whenever possible. Module 2 Module 2 (QOS) is the basis for the Question- based Review (QbR) used by the Office of Generic Drugs (OGD) I have no experience using it for a QbR Can be useful to get an overview of the application but not as the basis for the review. For Phase 1 INDs Module 3 without QOS is acceptable. Don t submit everything in the QOS. 4
5 One Single PDF Document vs Separate PDF Documents For small submissions, such as Phase 1 IND, single PDF document MIGHT appear to be acceptable but it isn t. The whole point of breaking the outline into separate sections is to avoid having to resubmit entire document when amendments are filed. Module 3 The most granular of the technical modules. Permits replacement of individual sections as updated. Can be challenging for reviewer since the reviewer has to go up and down the sections. 5
6 Links Internal links can be very useful, including to other Modules Useful to be able to link Batch Analysis to batches used for safety studies and clinical trials. If a different formulation was used during clinical development, link to P.2. Pharmaceutical Development Stability Data Provide data in tabular format. Clearly identify package type, strength. Useful to provide data by attribute in addition to by batch. Have SAS Transport files available as needed. Used for statistical analysis if needed. 6
7 Health Level 7 (HL7) Standards Develops standards for healthcare industry New FDA standards model Collaborate with standards development organizations like HL7 Adopt standards as appropriate Structured Product Labeling (SPL) Annotated Electrocardiogram (aecg) Various clinical data standards (e.g. CDISC) Regulatory Product Submission (RPS) which represents the evolution of the ectd HL7 Stability Model XML-based approach based on model created by FDA s Jon Clark & Naiqi i Ya Version 1 XML Schema approved and adopted as an ANSI standard in 2005 Industry-FDA working group established to test standard and associated Implementation Guide Version 2 submitted 7
8 FDA-Developed Sample Viewer Life Cycle Management Powerful tool, particularly for CMC. Permits tracking of tentative specs as they evolve, changes in manufacturing procedures Useful both pre-and post-approval 8
9 Post-Approval Submissions Relation to lifecycle management When constructing initial NDA submission consider impact on sections likely to be changed. What if baseline submission is not original NDA? What and when to back-populate? Post-Approval Submissions (contd) Supplements Consider adding a change history table to each document Module 1: Summarize ALL changes in cover letter Module 2: Use only when extensive changes Not for all data supporting the changes Module 3: Supporting data go here. Include only files that have been changed 9
10 Post-Approval Submissions (contd) Provide references to approved information Include baseline file if not already submitted Use Replace or Append Example: Add a new manufacturing site. Append another document containing additional site to existing document or replace existing list with a new list? Make changes to Module 3 documents obvious Tabular comparison, highlighting, Word s Track Changes, Best Practices Summary Include meaningful links & bookmarks Confirm that links work Include header or footer that identifies the file, and its version Limit submission of many small files Include short descriptive backbone file titles Be consistent Perform QA in the role of a reviewer Use related sequence number appropriately Facilitate comparisons of what s new/what s old 10
11 Conclusion Electronic submissions are a useful tool to permit easy access to information for reviewers but the submitter must follow the Guidances to facilitate review. Norman Schmuff Virginia Ventura Mark Seggel Acknowledgments 11
1 2 December esubmissions? 1. How can baseline dossiers support global esubmissions? Disclaimer. What is a baseline submission?
How can baseline dossiers support global Hans van Bruggen www.ectdconsultancy.com How can baseline dossiers support global 1 Disclaimer The views and opinions expressed in the following PowerPoint slides
More informationSteps to RPS Adoption
Steps to RPS Adoption Joel Finkle Advisor, Emerging Practices CSC Life Sciences BPS Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter
More informationCatherine Hosage Norman, Ph.D., RAC. January 11, 2012
Introduction to estability Catherine Hosage Norman, Ph.D., RAC January 11, 2012 Presentation Overview Stability Message Development Advantages of e-stability for the FDA & industry Style-sheet l h t e-stability
More informationectd TECHNICAL CONFORMANCE GUIDE
ectd TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions
More informationCase Study Update on Structured Content Approaches at Genzyme
Case Study Update on Structured Content Approaches at Genzyme Monica Mehta Director, Regulatory Operations Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the
More informationectd Tools Compatibility and Interoperability: Discussion and Practical Experience
ectd Tools Compatibility and Interoperability: Discussion and Practical Experience Gabriel Bohl, Regulatory Affairs Manager, Quintiles, France DIA EDM 3-4 Dec 2009 Vienna Disclaimer The views and opinions
More informationAdvantages of a real end-to-end approach with CDISC standards
Advantages of a real end-to-end approach with CDISC standards Dr. Philippe Verplancke CEO XClinical GmbH 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and opinions expressed
More informationGet ready for ectd in South Africa. Current status at MCC
Get ready for ectd in South Africa Current status at MCC E Taute Feb 2013 Overview Background Guidelines, Specifications, Forms ICH ectd Specification V 3.2.2 16-July-2008 2.21 South African Specification
More informationectd in Canada Ginette Larocque, Purdue Pharma Canada August 23, 2016
ectd in Canada Ginette Larocque, Purdue Pharma Canada August 23, 2016 AGENDA Eligibility for Filing in ectd Format ectd Mandatory? Structure and Content LCM Table and HC-SC 3011 Form Info Module 1 Administrative
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL Questions & Answers Implementation of ectd in South Africa This document is intended to provide clarity on guidelines and specifications for applications for the registration
More informationPreparing for FDA Mandated ectd Submissions
Preparing for FDA Mandated ectd Submissions Outsourcing in Clinical Trials West Coast 2016 11 Feb 2016 2 Agenda Introduction FDA Regulatory Background FDA Timetable International ectd What is an ectd Options
More informationBiotechnology Industry Organization 1225 Eye Street NW, Suite 400 Washington, DC 20006
Biotechnology Industry Organization 1225 Eye Street NW, Suite 400 Washington, DC 20006 December 22, 2003 Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville,
More informationGDUFA s Impact on ectds / Case Study: Implementing PDF Standards
GDUFA s Impact on ectds / Case Study: Implementing PDF Standards GPhA 2015 Fall Technical Conference GDUFA S Impact on ectds GPhA 2015 Fall Technical Conference 1 Introductions Kevin Tompkins Director,
More informationRevision of Technical Conformance Guide on Electronic Study Data Submissions
Notification No. 0824001 August 24, 2016 To: Prefectural Health Department (Bureau) Director of the Advanced Review with Electronic Data Promotion Group, Pharmaceuticals and Medical Devices Agency Revision
More informationData Integrity in Clinical Trials
Data Integrity in Clinical Trials DIA/ISPE Workshop 06-07 NOV 2014 Tom Haag, Novartis Pharmaceuticals Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual
More informationectd Practical experiences of the ectd pilot project and way forward
ectd Practical experiences of the ectd pilot project and way forward 26 August 2016 SAPRAA Estelle Taute 1 Overview Pilot Project Specifications & Guidelines Requirements vs Actual Validation issues Lifecycle
More informationOrientation Material for M8: ectd EWG ectd v4.0 Implementation Package v1.3
Orientation Material for M8: ectd EWG ectd v4.0 Implementation Package v1.3 International Council on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use 1 Legal Notice This presentation
More informationectd : Industry Experience
ectd : Industry Experience SAPRAA - 26 March 2010 Anita Smal Agenda Introduction Experience with MCC pilot project Lessons learnt ectd structure Life cycle Further guidance required from MCC Submission-ready
More informationThe ectd Backbone Files Specification for Module 1. The ectd BACKBONE FILES SPECIFICATION FOR MODULE 1
The ectd Backbone Files Specification for Module 1 The ectd BACKBONE FILES SPECIFICATION FOR MODULE 1 Revision History Date Version Summary of Changes 2003-08-13 1.0 Original version 2004-03-01 1.1 Clarifications
More informationGuidance for electronic submissions for Certificates of Suitability (CEP) applications
CBW/CB PUBLIC DOCUMENT (Level 1) English only/nglais seulement Strasbourg, January 2018 Certification of Suitability to the Monographs of the European Pharmacopoeia Guidance for electronic submissions
More informationFDA XML Data Format Requirements Specification
FDA XML Data Format Barry Brown, Product Integration Manager, Mortara Instrument Mark Kohls, Engineering Director, GE Medical Systems-Information Technologies Norman Stockbridge, M.D., Ph. D., Medical
More informationLex Jansen Octagon Research Solutions, Inc.
Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,
More informationectd Next Major Version Business Requirements (11-JUN-09)
ICH Req No. ICH01 ICH02 ICH03 ICH04 TOPIC APPLICATION APPLICATION APPLICATION APPLICATION ectd Next Major Version Business Requirements (11-JUN-09) Requirement A regulated product application may have
More informationMEDICINES CONTROL COUNCIL
CMs ZACTD MEDICINES CONTROL COUNCIL COMPLEMENTARY MEDICINES - USE OF THE ZA-CTD FORMAT IN THE PREPARATION OF A REGISTRATION APPLICATION This guideline is intended to provide recommendations to applicants
More informationICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD. Step 5
European Medicines Agency February 2004 CPMP/ICH/2887/99 ICH Topic M 4 Common Technical Document for the Registration of Pharmaceuticals for Human Use Organisation CTD Step 5 COMMON TECHNICAL DOCUMENT
More informationHow to write ADaM specifications like a ninja.
Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation
More informationCDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting
CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.
More informationPROPOSED DOCUMENT. International Medical Device Regulators Forum
PROPOSED DOCUMENT International Medical Device Regulators Forum Title: Assembly and Technical Guide for IMDRF Table of Contents (ToC) Submissions (ToC-based submissions) Authoring Group: Regulated Product
More informationUS Food and Drug Administration. Revision History
Specifications for ectd Validation Criteria US Food and Drug Administration Specifications for ectd Validation Criteria Revision History Date Description Version 2008-03-10 Initial Release of ectd Validation
More informationectd Next Major Release Business Requirements Collation (11 NOV 10) TOPIC Requirement Comment ICH Req No.
ICH Req No. ICH001 ICH002 ICH003 ICH004 ectd Next Major Release Business Requirements Collation (11 NOV 10) TOPIC Requirement Comment A regulated product application may have one or more regulatory activities
More informationGuidance for electronic and paper submissions for Certificates of Suitability (CEP) applications
FK/CB PUBLIC DOCUMENT (LEVEL 1) English only/nglais seulement Strasbourg, June 2013 Certification of suitability to Monographs of the European Pharmacopoeia Guidance for electronic and paper submissions
More informationPOLICY AND PROCEDURES OFFICE OF SURVEILLANCE AND EPIDEMIOLOGY. Procedures for Handling Requests for Proprietary Name Review.
POLICY AND PROCEDURES OFFICE OF SURVEILLANCE AND EPIDEMIOLOGY Procedures for Handling Requests for Proprietary Name Review Table of Contents PURPOSE...1 BACKGROUND...1 POLICY...2 RESPONSIBILITIES AND PROCEDURES...3
More informationClinical Data Model and FDA Submissions
Clinical Data Model and FDA Submissions Shy Kumar, Datafarm, Inc., Marlboro, MA Gajanan Bhat, Boston Scientific Corporation, Natick, MA ABSTRACT Development of data model in clinical trial management environment
More informationGet ready for ectd in South Africa
Get ready for ectd in South Africa Going from CTD to ectd Anita Smal, 14 & 15 February 2013 Agenda The goal Planning Prepare submission ready documents PDFs ectd content planning ectd structure planning
More informationectd Next Major Release Business Requirements Collation (9-JUN-10) TOPIC Requirement Comment
ICH Req No. ectd Next Major Release Business Requirements Collation (9-JUN-10) TOPIC Requirement Comment ICH001 ICH002 ICH003 ICH004 APPLICATION APPLICATION APPLICATION APPLICATION A regulated product
More information12/2/2011. Integration of s into the Trial Master File. Russell Joyce. Heath Barrowcliff Consulting Ltd. Disclaimer
Integration of emails into the Trial Master File Russell Joyce Director & Principal i Consultant t Heath Barrowcliff Consulting Ltd Disclaimer The views and opinions expressed in the following PowerPoint
More informationUDI progress in China
UDI progress in China Research & Supervision Division, Device Registration Department, NMPA Li Jun November 1,2018 Context Background General Idea Highlights Next steps summary 研究背景 研究方法 Background Policy
More informationAPI documentation from the perspective of WHO-PQP
API documentation from the perspective of WHO-PQP Antony Fake PhD WHO Medicines Prequalification Programme 1 API documentation 3.2.S.3.2 from Impurities, the perspective of WHO PQP Malaysia, Mumbai, 29
More informationHow a Metadata Repository enables dynamism and automation in SDTM-like dataset generation
Paper DH05 How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Judith Goud, Akana, Bennekom, The Netherlands Priya Shetty, Intelent, Princeton, USA ABSTRACT The traditional
More informationUpdate of ectd Module 1 specification for South Africa V2.0
Update of ectd Module 1 specification for South Africa V2.0 Dr. Silke Nolkemper, Senior Business Consultant Christine Hirt, Managing Consultant Pretoria Copyright 2016 EXTEDO. All rights reserved. 2 New
More information1. Document Control 2. Change Record Version Date Author(s) Comments 3. Reviewers Version Name Organisation 4. Distribution Version Date Name Status
for the paper submission of regulatory information in support of a marketing authorisation application when using the Electronic Common Technical Document ( ectd ) as the source submission. V1.0 February
More informationIEEE Development Program - Overview. d1jw
IEEE 11073 Development Program - Overview d1jw Contents Program management perspective Development phasing perspectives Functional Temporal Supporting perspectives (Appendices) A: Project/Program context
More informationRPS/ICH Requirements. sequence number values would need to be unique to each application. principle. 1 of 14
o. ICH01 ectd ext Major Release Business Requirements Collation (12 OV 08) APPLICATIO A regulated product application may have one or LIFECCLE more regulatory activities associated with it RPS 1 included
More informationOpenCDISC Validator 1.4 What s New?
OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation
More informationAPACMed Workshop Update on UDI Implementation & ASPAC Regional Trend. Victoria Qu Sept. 22 nd, 2017
APACMed Workshop Update on UDI Implementation & ASPAC Regional Trend Victoria Qu Sept. 22 nd, 2017 1 Disclaimer / 免责声明 The views and opinions expressed in the following PowerPoint slides are those of the
More informationComparison of FDA and PMDA Requirements for Electronic Submission of Study Data
Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data Monika Kawohl Statistical Programming Accovion CDISC GSUG Meeting 15-Sep-2015 1 References FDA Website: Study Data Standards
More informationCommon Statistical Analysis Plan (SAP) Frequently Asked Questions
Last Updated 4-Nov-2018 Topics 1 Stakeholder Input to Common SAP Template Development... 2 2 Template Content... 2 3 Implementation of the Common SAP template by the Sponsor... 55 4 Updates to the Common
More informationPharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data
An Approach to CDISC SDTM Implementation for Clinical Trials Data William T. Chen, Merck Research Laboratories, Rahway, NJ Margaret M. Coughlin, Merck Research Laboratories, Rahway, NJ ABSTRACT The Clinical
More informationLOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office SOP 1027 LU
LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE Loughborough University (LU) Research Office SOP 1027 LU Process for Writing Study Protocols for NHS Research Sponsored by Loughborough
More informationPreparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA
PharmaSUG 2018 - Paper EP15 Preparing the Office of Scientific Investigations (OSI) Requests for Submissions to FDA Ellen Lin, Wei Cui, Ran Li, and Yaling Teng Amgen Inc, Thousand Oaks, CA ABSTRACT The
More informationSubmitting High Quality ectd Submissions to FDA/OGD
Submitting High Quality ectd Submissions to FDA/OGD GPhA/FDA ANDA Labeling Workshop/ USP User Forum September 11, 2013 Constance Robinson Regulatory Information Specialist edata Management Solutions Team
More informationStudy Data Reviewer s Guide Completion Guideline
Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on
More informationRelease Notes for TIGes ectd Guidance Comparison of version 2.0 with 1.0
General Changes throughout the document Previous NA Changes EMEA changed to EMA Cover Page NA Draft status of document removed. Changed the name of the document. 1. Introduction 1 Fully rewritten to align
More informationImportant Notes: The XML and there corresponding images should be added with the proper file names.
ectd FAQ Contents ECTD HOW TO GUIDE... 3 SPL Naming Convention in ectd... 3 Procedure to Send SPC documents in WORD format... 4 File name exceeds maximum length (64 characters) per ectd specification...
More informationM2 Glossary of Terms and Abbreviations
M2 Glossary of Terms and Abbreviations 11 June 2015 M2: Electronic Standards for the Transfer of Regulatory Information Updated at ICH Expert Working Group meeting, Fukuoka, June 2015 Definitions... 2
More informationSite User Guide. Oracle Health Sciences InForm CRF Submit Release Part Number:E
Site User Guide Oracle Health Sciences InForm CRF Submit Release 4.0.2 Part Number:E79080-01 Copyright 2016, 2017, Oracle and/or its affiliates. All rights reserved. This software and related documentation
More informationAbout Domestic Implementation of the Electronic File Specifications to Be Included in the ICH Electronic Common Technical Document (ectd) v1.1.
Appendix 2 About Domestic Implementation of the Electronic File Specifications to Be Included in the ICH Electronic Common Technical Document (ectd) v1.1.0 between the Japanese original and the English
More informationTips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA
PharmaSUG 2015 - Paper IB09 Tips on Creating a Strategy for a CDISC Submission Rajkumar Sharma, Nektar Therapeutics, San Francisco, CA ABSTRACT A submission to FDA for an NDA (New Drug Application) or
More informationectd Next Major Version / Regulated Product Submission
ectd Next Major Version / Regulated Product Submission Trusted ectd Solutions At GlobalSubmit, we re not only thought leaders, we re trusted advisors to the FDA, to our clients and to agencies worldwide.
More informationQuality Overall Summary Grounds for Revision
Quality Overall Summary Grounds for Revision Jean-Louis ROBERT, Ph.D. National Health Laboratory Luxembourg (EU) Diagrammatic Representation Module 2{ Quality Overall Summary 2.3 Module 1 1.0 Regional
More informationUser Scripting April 14, 2018
April 14, 2018 Copyright 2013, 2018, Oracle and/or its affiliates. All rights reserved. This software and related documentation are provided under a license agreement containing restrictions on use and
More informationVariations in ectd format Q&A document
February 2015 Q&A document This document uses a question and answer format to give some guidance when submitting variation applications in ectd format. For general guidance on variations, please refer
More informationQuality Overall Summary Chemical Entities Clinical Trial Application Phase III QOS - CTA GRP(PQ)-01-1(v1): Date 2008/11/12
Therapeutic Products Directorate To: [Name], Director, Office of Clinical Trials Security Classification: HC Protected From: [Name], Manager, Clinical Trials Quality Division, Office of Clinical Trials
More informationLex Jansen Octagon Research Solutions, Inc.
Converting the define.xml to a Relational Database to Enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D * PharmaSUG 2009,
More informationNatural Health Products Online Solution: Electronic Submission Builder User Manual
Natural Health Products Online Solution: Electronic Submission Builder User Manual Table of Contents 1 Introduction... 4 1.1 Overview... 4 1.2 Quickstart to the esubmission Builder (esb)... 4 2 System
More informationThe ectd BACKBONE FILES SPECIFICATION FOR MODULE 1
The ectd BACKBONE FILES SPECIFICATION FOR MODULE 1 Revision History Date Version Summary of Changes 2003-08-13 1.0 Original version 2004-03-01 1.1 Clarifications to the original version 2006-04-13 1.2
More informationElements of Data Management
Elements of Data Management Disclaimers: The views in this presentation represent those of the presenter and not necessarily those of Bayer, CVM, SQA or KSU. Names used in examples are fictional and not
More information-Evolving ectd Technology Transforming Global Regulatory Submission Strategy. PART TWO 30-Mar ectd MASTERCLASS 1
ectd MASTERCLASS -Evolving ectd Technology Transforming Global Regulatory Submission Strategy PART TWO 30-Mar-2016 ectd MASTERCLASS 1 Session Chair Handsome Ji Senior Publishing Team Manager, Worldwide
More informationALBERTA ADVERSE EVENT FOLLOWING IMMUNIZATION(AEFI) HL7 MESSAGING SPECIFICATION
Health Information Messaging Specification HEALTH INFORMATION STANDARDS COMMITTEE FOR ALBERTA ALBERTA ADVERSE EVENT FOLLOWING IMMUNIZATION(AEFI) HL7 MESSAGING SPECIFICATION MESSAGE STANDARD SUMMARY Status:
More informationMaterial covered in the Dec 2014 FDA Binding Guidances
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material
More informationEMC Documentum Quality and Manufacturing
EMC Documentum Quality and Manufacturing Version 3.1 User Guide EMC Corporation Corporate Headquarters Hopkinton, MA 01748-9103 1-508-435-1000 www.emc.com Legal Notice Copyright 2012-2016 EMC Corporation.
More informationOracle Argus Safety. Service Administrator s Guide Release E
Oracle Argus Safety Service Administrator s Guide Release 6.0.1 E15949-02 January 2011 Oracle Argus Safety Service Administrator's Guide Release 6.0.1 E15949-02 Copyright 2009, 2011 Oracle and/or its affiliates.
More informationUser Guide 16-Mar-2018
16-Mar-2018 This document is freely distributable Identification Authors Name Organization Title TMF User Guide and Implementation Guide Sub-Team Version History Version Steering Committee Approval Date
More informationPre-notification check for type IB Variations 1
Pre-notification check for type IB Variations 1 This pre-notification checklist is aimed at facilitating submission of complete and correct Type IB variation notifications by Marketing Authorisation Holders
More informationAn Alternate Way to Create the Standard SDTM Domains
PharmaSUG 2018 - Paper DS-12 ABSTRACT An Alternate Way to Create the Standard SDTM Domains Sunil Kumar Pusarla, Omeros Corporation Sponsors who initiate clinical trials after 2016-12-17 are required to
More informationCost-Benefit Analysis of Retrospective vs. Prospective Data Standardization
Cost-Benefit Analysis of Retrospective vs. Prospective Data Standardization Vicki Seyfert-Margolis, PhD Senior Advisor, Science Innovation and Policy Food and Drug Administration IOM Sharing Clinical Research
More informationDesign of Case Report Forms. Case Report Form. Purpose. ..CRF Official clinical data-recording document or tool used in a clinical study
Design of Case Report Forms David W. Mailhot February 23, 2010 Case Report Form..CRF Official clinical data-recording document or tool used in a clinical study PAPER RDC/RDE (Remote Data Capture, Remote
More informationZambia Medicines Regulatory Authority APPLICATION FOR MARKETING AUTHORISATION OF A MEDICINE FOR HUMAN USE
Zambia Medicines Regulatory Authority APPLICATION FOR MARKETING AUTHORISATION OF A MEDICINE FOR HUMAN USE COMMON TECHNICAL DOCUMENT FORMAT ZAMBIA Module 1 CTD-Modules 2-5 Version 03, April 2015 ZAMBIA
More informationStandards Metadata Management (System)
Standards Metadata Management (System) Kevin Lee, MarkLogic COPYRIGHT 2015 MARKLOGIC CORPORATION. ALL RIGHTS RESERVED. Agenda Regulatory Requirement on Clinical Trial Standards(i.e., CDISC and ectd) Standards
More informationICH M8 Expert Working Group. Specification for Submission Formats for ectd v1.1
INTERNATIONAL COUNCIL FOR HARMONISATION OF TECHNICAL REQUIREMENTS FOR PHARMACEUTICALS FOR HUMAN USE ICH M8 Expert Working Group Specification for Submission Formats for ectd v1.1 November 10, 2016 DOCUMENT
More informationCBER STUDY DATA STANDARDS UPDATE
CBER STUDY DATA STANDARDS UPDATE Lisa Lin, MBA Study Data Standards Manager Office of the Director Center for Biologics Evaluation and Research U.S. Food & Drug Administration PhUSE US Connect Raleigh,
More informationDataset-XML - A New CDISC Standard
Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL STANDARDISED PACKAGE INSERTS FOR HUMAN MEDICINES The purpose of this document is to define the criteria for developing standardised package inserts (SPI) and for the use of an
More informationHealthcare Information Technology Standards Panel (HITSP) - FOR INFORMATION. HITSP-USHIK Quick Start Guide & USHIK Overview
Document Number: HITSP 10 N 462 Date: February 3, 2010 TO: Healthcare Information Technology Standards Panel (HITSP) - FOR INFORMATION FROM: RE: Michelle Maas Deane HITSP Secretariat American National
More informationGuideline on the specifications for provision of an electronic submission (e-submission) for a veterinary medicinal product
Guideline prepared by the TIGes-Vet Version 1.0 June 2009 Guideline on the specifications for provision of an electronic submission (e-submission) for a veterinary medicinal product 1. Introduction This
More informationIntroduction to ADaM and What s new in ADaM
Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis
More informationPharmaSUG. companies. This paper. will cover how. processes, a fairly linear. before moving. be carried out. Lifecycle. established.
PharmaSUG 2016 - Paper PO17 Standards Implementationn & Governance: Carrot or Stick? Julie Smiley, Akana, San Antonio, Texas Judith Goud, Akana, Bennekom, Netherlands ABSTRACT With the looming FDA mandate
More informationANSM 11/ Page 1 sur 6
NOTICE TO ASMF HOLDERS FOR ELECTRONIC SUBMISSION OF ASMF TO ANSM VIA CESP... 2 1. ectd Format... 2 a. MR/DC Procedures... 2 b. National Procedures... 2 c. ASMF Guidance... 2 d. Recommendations... 2 2.
More informationThe Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008
The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits
More informationImplementation of UDI In the Medical Device Industry
Implementation of UDI In the Medical Device Industry IMDRF UDI Workshop - Brussels, Belgium Monday, 12 February 2018 Jackie Rae Elkin - Global Medical Technology Alliance (GMTA) James Turner - Global Diagnostic
More informationVersion Control of Study Specific Documents
SOP Title Version Control of Study Specific Documents SOP No. SOP 10 Author Consulted Departments Lead Manager Sign and Print Name Julia Farmery Revision V2.0: Sarah Fahy Lincolnshire Clinical Research
More informationGuidance for Industry on Providing Regulatory Information in Electronic Format: ectd electronic Submissions
DRAFT FOR TESTING Guidance for Industry on Providing Regulatory Information in Electronic Format: ectd electronic Submissions This document is published under the auspices of the EU Telematic Implementation
More informationAutomate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.
Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o
More informationQuick Notes Table of Contents
Quick Notes Table of Contents How to add the Image in SPL Editor?... 2 How to add the alternative text for an image?... 6 How to Add or Delete Bookmark?... 7 Add Bookmark... 7 Delete Bookmark... 9 How
More informationNew Applications of the VD max Approach to Substantiation of Preselected Sterilization Doses: VD max
New Applications of the VD max Approach to Substantiation of Preselected Sterilization Doses: VD max 12.5, VD max Values Derived for Specific Product Use, and Sterility Assurance Levels Greater than 10-6
More informationOracle Life Sciences Data Hub
Oracle Life Sciences Data Hub Implementation Guide Release 2.2 E22744-02 June 2011 Oracle Life Sciences Data Hub Implementation Guide, Release 2.2 E22744-02 Copyright 2006, 2011, Oracle and/or its affiliates.
More informationExample of QbD Application in Japan Yoshihiro Matsuda, Ph.D.
Example of QbD Application in Japan Yoshihiro Matsuda, Ph.D. Senior Scientist (for Quality) Pharmaceuticals and Medical Devices Agency (PMDA) Aug 11, 2016 1 Agenda Introduction of PMDA QbD assessment experience
More informationTraceability Look for the source of your analysis results
Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,
More informationManagement of RMP for CAPs in postauthorisation
Management of RMP for CAPs in postauthorisation EMA perspective Presented by Iordanis Gravanis on 9 November 2015 Head of Evaluation Procedures C, Procedure Management (and Committees Support) An agency
More informationSupport Notes (Issue 1) September Snap it! Certificate in Digital Applications (DA105) Coding for the Web
Support Notes (Issue 1) September 2014 Certificate in Digital Applications (DA105) Coding for the Web Snap it! Introduction Before tackling the Summative Project Brief (SPB), students should have acquired
More information